Qiagen (NASDAQ:QGEN) will post its quarterly earnings results after the market closes on Wednesday, January 31st. Analysts expect Qiagen to post earnings of $0.41 per share for the quarter. Qiagen has set its Q4 guidance at $0.41-0.42 EPS.
Qiagen (NASDAQ:QGEN) last posted its earnings results on Monday, November 6th. The company reported $0.32 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.32. Qiagen had a return on equity of 11.36% and a net margin of 6.40%. The firm had revenue of $364.00 million for the quarter, compared to analyst estimates of $363.42 million. During the same quarter in the prior year, the company earned $0.29 EPS. Qiagen’s revenue was up 7.5% on a year-over-year basis. On average, analysts expect Qiagen to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Qiagen (NASDAQ QGEN) opened at $33.55 on Wednesday. Qiagen has a 12 month low of $27.51 and a 12 month high of $36.34. The company has a current ratio of 5.33, a quick ratio of 4.78 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $7,740.00, a PE ratio of 86.03, a P/E/G ratio of 1.83 and a beta of 1.10.
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials.
Receive News & Ratings for Qiagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen and related companies with MarketBeat.com's FREE daily email newsletter.